Randomized trial of oral adjuvant razoxane (ICRF 159) in resectable colorectal cancer: Five‐year follow‐up
暂无分享，去创建一个
J. Gilbert | K. Hellmann | C. Wastell | H. Ellis | M. Evans | R. Taylor | P. Cassell | B. Stoodley | M. Evanst | The Royal | Mr J. M. Gilbert | P. Cassell | follow-J. M. Gilbert | R. H. Taylor | B. Stoodley5